Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

n cancer cells, a protein that acts as a central regulator of tumor cell division, blood vessel growth and cell metabolism. Everolimus is being studied in multiple tumor types, including breast cancer, neuroendocrine tumors, gastric cancer, hepatocellular carcinoma (HCC) and non-Hodgkin lymphoma (NHL), as well as tuberous sclerosis complex (TSC).

As an investigational compound, the safety and efficacy profile of everolimus has not yet been established in these cancer and tumor types. Access to everolimus for these cancer and tumor types is available through carefully controlled and monitored clinical trials. These trials are designed to better understand the potential benefits and risks of the compound. For more information about everolimus clinical trials, healthcare professionals can visit www.theWIDEprogram.com. Because of the uncertainty of clinical trials, there is no guarantee that everolimus will ever become commercially available for these cancer and tumor types anywhere in the world.

Afinitor (everolimus) tablets important safety information

Afinitor is contraindicated in patients with hypersensitivity to everolimus, to other rapamycin derivatives or to any of the excipients. Potentially serious adverse reactions to Afinitor include non-infectious pneumonitis and infections, for which patients should be monitored carefully and treated as needed. In addition, non-infectious pneumonitis may require temporary dose reduction and/or interruption or discontinuation. Patients with systemic invasive fungal infections should not receive Afinitor. Oral ulceration is a common side effect of Afinitor. Renal function, blood glucose, lipids and hematological parameters should be evaluated prior to the start of therapy with Afinitor and periodically thereafter. Strong or moderate CYP3A4 or P-glycoprotein inhibitors should be avoided. An increase in the dose of Afinitor is
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)...  Mark Riccio, director of Cornell University,s multi-scale ... the online crowd-funding platform Kickstarter to bring non-invasive ... and would-be superheros everywhere: "for FREE." Riccio,s campaign, ... if you had Superman,s X-ray vision?" The campaign ... from elementary through high school students, academic institutions, ...
(Date:8/22/2014)...  Landauer, Inc. (NYSE: LDR ), a ... monitoring, outsourced medical physics services and high quality medical ... , its President and Chief Executive Officer, will be ... as a member of the Board of Directors, effective ... on an interim basis by Michael T. Leatherman ...
(Date:8/21/2014)... , Aug. 21, 2014  Aptuit LLC ... West Lafayette, Indiana , has enhanced its ... characterization of small and large molecules, including biologic ... the Bruker maXisPlus Q-TOF mass spectrometer. ... , CEO, Aptuit, said, "The expanded large molecule ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2Landauer, Inc. Announces Executive Management Change 2Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2
(Date:8/22/2014)... -- Back-to-school time provides an opportunity for parents to ... schedules, an expert suggests. "Forget New Year,s resolutions; ... be the start of a new fitness and exercise ... at the University of the Sciences in Philadelphia, said ... activities likely to build up, "it,s important for mom ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Dayton Children's Hospital ... tower as part of a $141 million campus renewal. ... care tower were unveiled to the public. , The ... plan that will create a campus that meets the needs ... These new care spaces will embody Dayton Children’s unique patient ...
(Date:8/22/2014)... blockages in the kidney arteries may benefit patients ... trials, according to new recommendations for renal artery ... today by the Society for Cardiovascular Angiography ... Center,s Sahil Parikh, MD, Director, Interventional Cardiology Fellowship ... University School of Medicine was the lead author ...
(Date:8/22/2014)... PA (PRWEB) August 22, 2014 Menstrual ... An inventor from Sunrise, Fla., decided that there needed ... , Easy to use and producible in design variations, ... stains caused by leaks, which avoids embarrassment and promotes ... to conventional sanitary pads. , The original design was ...
(Date:8/22/2014)... People who use reduced-nicotine cigarettes don,t smoke more to ... to a new study. This means they don,t ... say. The month-long study included 72 adult smokers, ... nicotine emission levels of 1.2 milligrams (mg) each for ... for the next three weeks. In each of ...
Breaking Medicine News(10 mins):Health News:With Kids in School, Parents Can Work Out 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3Health News:Low-Nicotine Cigarettes May Not Lead to More Smoking 2
... study accepted for publication in The Endocrine Society,s ... that shift work at a young age is ... BMI. Previous studies have shown that long-term elevated ... diabetes and cardiovascular risk. Shift work, defined ...
... 60 per cent of people who have a stroke experience ... own homes and some are left with serious injuries, ... Congress. Better identification of people at risk of ... homes, are required to keep people safe and injury-free, says ...
... surface they appear unaffected, but people who have mild strokes ... difficulty thinking, according to a study released today at the ... guidelines for the treatment and management of mild strokes, which ... hospital stay of one to five days. Co-author Annie Rochette, ...
... -- Every year millions of babies and toddlers receive ... ear surgery. Now, researchers at Mayo Clinic in Rochester ... requiring general anesthesia before age 2 and learning disabilities ... published in the November 2011 issue of Pediatrics ...
... , SATURDAY, Oct. 1 (HealthDay News) -- Many American ... young an age, a new study indicates. Rear-facing car ... American Academy of Pediatrics guidelines. But a national survey ... Children,s Hospital found that 73 percent of parents of children ...
... BEACH, FL (October 2, 2011) Radiosurgery is a non-invasive ... target tumors and other abnormalities in the body. A ... a lesion that might not be amenable to surgical ... CyberKnife (CK), can be relatively time-consuming because the treatment ...
Cached Medicine News:Health News:Prevention measures needed to address major risk of falls after stroke 2Health News:More screening needed to identify depression, vision loss after mild stroke 2Health News:More screening needed to identify depression, vision loss after mild stroke 3Health News:Mayo Clinic study: multiple surgeries and anesthesia exposure 2Health News:Keep Kids in Rear-Facing Car Seats Until Age 2 2Health News:Fox Chase researchers identifiy more accurate treatment delivery for robotic radiosurgery system 2
Every so often a new product comes along that isn't a small step but a giant leap ahead of everything that has preceeded it. Such is the impact of the Fidelity IAB....
... new top-line range of digital pacemakers for ... (AF). Because the T-series combines digital technology ... of AF is taken one step further. ... rhythm is monitored continuously and extensively. This ...
... The MyLab30CV ultrasound system is an evolutionary ... 20 pounds, it is the first compact ... And with mobile, portable or stationary configurations, ... MyLab30CV is the perfect combination of ...
... changes the way anatomy is imaged and ... Series of scanners combine superior resolution with ... patients or procedures more routine., The LightSpeed ... to new procedures while improving the imaging ...
Medicine Products: